Annual Accounts Payable
$25.44 M
+$4.94 M+24.08%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual accounts payable is currently $25.44 million, with the most recent change of +$4.94 million (+24.08%) on 31 December 2023. During the last 3 years, it has risen by +$1.08 million (+4.44%). AMPH annual accounts payable is now -18.79% below its all-time high of $31.32 million, reached on 31 December 2018.AMPH Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$34.09 M
+$2.31 M+7.28%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly accounts payable is currently $34.09 million, with the most recent change of +$2.31 million (+7.28%) on 30 September 2024. Over the past year, it has increased by +$2.12 million (+6.62%). AMPH quarterly accounts payable is now -6.70% below its all-time high of $36.53 million, reached on 31 March 2024.AMPH Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.1% | +6.6% |
| 3 y3 years | +4.4% | +57.4% |
| 5 y5 years | -18.8% | +54.6% |
AMPH Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +24.1% | -6.7% | +81.0% |
| 5 y | 5 years | -18.8% | +24.1% | -6.7% | +106.5% |
| alltime | all time | -18.8% | +150.3% | -6.7% | +255.4% |
Amphastar Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $34.09 M(+7.3%) |
| June 2024 | - | $31.77 M(-13.0%) |
| Mar 2024 | - | $36.53 M(+43.6%) |
| Dec 2023 | $25.44 M(+24.1%) | $25.44 M(-20.4%) |
| Sept 2023 | - | $31.97 M(+69.8%) |
| June 2023 | - | $18.83 M(-14.3%) |
| Mar 2023 | - | $21.98 M(+7.2%) |
| Dec 2022 | $20.50 M(-7.7%) | $20.50 M(+2.7%) |
| Sept 2022 | - | $19.96 M(-35.8%) |
| June 2022 | - | $31.07 M(+30.3%) |
| Mar 2022 | - | $23.84 M(+7.3%) |
| Dec 2021 | $22.21 M(-8.8%) | $22.21 M(+2.6%) |
| Sept 2021 | - | $21.66 M(-22.0%) |
| June 2021 | - | $27.75 M(+20.7%) |
| Mar 2021 | - | $22.99 M(-5.6%) |
| Dec 2020 | $24.36 M(-2.8%) | $24.36 M(+5.1%) |
| Sept 2020 | - | $23.17 M(+6.7%) |
| June 2020 | - | $21.71 M(+31.5%) |
| Mar 2020 | - | $16.51 M(-34.1%) |
| Dec 2019 | $25.06 M | $25.06 M(+13.7%) |
| Sept 2019 | - | $22.04 M(-29.9%) |
| June 2019 | - | $31.46 M(-8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $34.27 M(+9.4%) |
| Dec 2018 | $31.32 M(+88.4%) | $31.32 M(+38.2%) |
| Sept 2018 | - | $22.67 M(+4.6%) |
| June 2018 | - | $21.66 M(+38.6%) |
| Mar 2018 | - | $15.63 M(-6.0%) |
| Dec 2017 | $16.63 M(-16.6%) | $16.63 M(+73.4%) |
| Sept 2017 | - | $9.59 M(-35.7%) |
| June 2017 | - | $14.91 M(-22.8%) |
| Mar 2017 | - | $19.30 M(-3.2%) |
| Dec 2016 | $19.93 M(+43.7%) | $19.93 M(+48.3%) |
| Sept 2016 | - | $13.44 M(-28.4%) |
| June 2016 | - | $18.77 M(+0.8%) |
| Mar 2016 | - | $18.62 M(+34.2%) |
| Dec 2015 | $13.87 M(+36.5%) | $13.87 M(+13.1%) |
| Sept 2015 | - | $12.27 M(-33.5%) |
| June 2015 | - | $18.45 M(-2.6%) |
| Mar 2015 | - | $18.95 M(+86.5%) |
| Dec 2014 | $10.16 M(-50.1%) | $10.16 M(+1.5%) |
| Sept 2014 | - | $10.01 M(-43.6%) |
| June 2014 | - | $17.76 M(+1.1%) |
| Mar 2014 | - | $17.57 M(-13.8%) |
| Dec 2013 | $20.38 M(+15.4%) | $20.38 M |
| Dec 2012 | $17.66 M | - |
FAQ
- What is Amphastar Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual accounts payable year-on-year change?
- What is Amphastar Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly accounts payable year-on-year change?
What is Amphastar Pharmaceuticals annual accounts payable?
The current annual accounts payable of AMPH is $25.44 M
What is the all time high annual accounts payable for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual accounts payable is $31.32 M
What is Amphastar Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, AMPH annual accounts payable has changed by +$4.94 M (+24.08%)
What is Amphastar Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of AMPH is $34.09 M
What is the all time high quarterly accounts payable for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly accounts payable is $36.53 M
What is Amphastar Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, AMPH quarterly accounts payable has changed by +$2.12 M (+6.62%)